12160 related articles for article (PubMed ID: 10661765)
1. Efficient in vivo targeting of malignant melanoma by single-chain Fv antibody fragments.
Kang NV; Hamilton S; Sanders R; Wilson GD; Kupsch JM
Melanoma Res; 1999 Dec; 9(6):545-56. PubMed ID: 10661765
[TBL] [Abstract][Full Text] [Related]
2. In vivo targeting of malignant melanoma by 125Iodine- and 99mTechnetium-labeled single-chain Fv fragments against high molecular weight melanoma-associated antigen.
Kang N; Hamilton S; Odili J; Wilson G; Kupsch J
Clin Cancer Res; 2000 Dec; 6(12):4921-31. PubMed ID: 11156253
[TBL] [Abstract][Full Text] [Related]
3. Characterization of human anti-high molecular weight-melanoma-associated antigen single-chain Fv fragments isolated from a phage display antibody library.
Desai SA; Wang X; Noronha EJ; Kageshita T; Ferrone S
Cancer Res; 1998 Jun; 58(11):2417-25. PubMed ID: 9622083
[TBL] [Abstract][Full Text] [Related]
4. Reducing renal accumulation of single-chain Fv against melanoma-associated proteoglycan by coadministration of L-lysine.
Hamilton S; Odili J; Wilson GD; Kupsch JM
Melanoma Res; 2002 Aug; 12(4):373-9. PubMed ID: 12170187
[TBL] [Abstract][Full Text] [Related]
5. The use of a cocktail of single chain Fv antibody fragments to improve the in vitro and in vivo targeting of melanoma.
Pacifico MD; Pearl RA; Kupsch JM
J Exp Clin Cancer Res; 2006 Mar; 25(1):45-53. PubMed ID: 16761617
[TBL] [Abstract][Full Text] [Related]
6. Generation and selection of monoclonal antibodies, single-chain Fv and antibody fusion phage specific for human melanoma-associated antigens.
Kupsch JM; Tidman N; Bishop JA; McKay I; Leigh I; Crowe JS
Melanoma Res; 1995 Dec; 5(6):403-11. PubMed ID: 8589614
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and biodistribution of genetically-engineered antibodies.
Colcher D; Pavlinkova G; Beresford G; Booth BJ; Choudhury A; Batra SK
Q J Nucl Med; 1998 Dec; 42(4):225-41. PubMed ID: 9973838
[TBL] [Abstract][Full Text] [Related]
8. Phage-selected primate antibodies fused to superantigens for immunotherapy of malignant melanoma.
Tordsson JM; Ohlsson LG; Abrahmsén LB; Karlström PJ; Lando PA; Brodin TN
Cancer Immunol Immunother; 2000 Mar; 48(12):691-702. PubMed ID: 10752477
[TBL] [Abstract][Full Text] [Related]
9. Biodistribution study of murine monoclonal anti-GD3 antibody in nude mice bearing human melanoma xenografts for development of immunoscintigraphy.
Ojima F; Ido T; Kijima-Suda I; Nakagawa Y
Tohoku J Exp Med; 1998 Jun; 185(2):89-100. PubMed ID: 9747648
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and biodistribution of 177Lu-labeled multivalent single-chain Fv construct of the pancarcinoma monoclonal antibody CC49.
Chauhan SC; Jain M; Moore ED; Wittel UA; Li J; Gwilt PR; Colcher D; Batra SK
Eur J Nucl Med Mol Imaging; 2005 Mar; 32(3):264-73. PubMed ID: 15791435
[TBL] [Abstract][Full Text] [Related]
11. A quantitative analysis of tumor specific monoclonal antibody uptake by human melanoma xenografts: effects of antibody immunological properties and tumor antigen expression levels.
Shockley TR; Lin K; Sung C; Nagy JA; Tompkins RG; Dedrick RL; Dvorak HF; Yarmush ML
Cancer Res; 1992 Jan; 52(2):357-66. PubMed ID: 1728407
[TBL] [Abstract][Full Text] [Related]
12. Targeting of bivalent anti-ErbB2 diabody antibody fragments to tumor cells is independent of the intrinsic antibody affinity.
Nielsen UB; Adams GP; Weiner LM; Marks JD
Cancer Res; 2000 Nov; 60(22):6434-40. PubMed ID: 11103810
[TBL] [Abstract][Full Text] [Related]
13. Increased affinity leads to improved selective tumor delivery of single-chain Fv antibodies.
Adams GP; Schier R; Marshall K; Wolf EJ; McCall AM; Marks JD; Weiner LM
Cancer Res; 1998 Feb; 58(3):485-90. PubMed ID: 9458094
[TBL] [Abstract][Full Text] [Related]
14. Improvement by affinity chromatography on antiidiotypic monoclonal antibodies (MAbs) of immunoreactivity and in vivo targeting of radiolabelled anti-HMW-MAA MAb TP61.5 in nude mice bearing human melanoma lesions.
Temponi M; Fawwaz RA; Kekish U; Wang TS; Ferrone S
Int J Cancer; 1991 Oct; 49(4):624-30. PubMed ID: 1917164
[TBL] [Abstract][Full Text] [Related]
15. Limited diversity of human scFv fragments isolated by panning a synthetic phage-display scFv library with cultured human melanoma cells.
Noronha EJ; Wang X; Desai SA; Kageshita T; Ferrone S
J Immunol; 1998 Sep; 161(6):2968-76. PubMed ID: 9743360
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of the growth of human melanoma metastases in nude mice by melanoma-specific murine monoclonal antibody.
Abdel-Wahab ZA; Darrow TL; Vervaert CE; Giannopoulou AA; Li W; Seigler HF
Surg Oncol; 1992 Apr; 1(2):115-25. PubMed ID: 1341242
[TBL] [Abstract][Full Text] [Related]
17. Improved tumor targeting of rhenium-186-labeled anti-human high-m.w. melanoma-associated antigen monoclonal antibody 763.74 following purification with anti-idiotypic monoclonal antibody MK2-23.
Hamby CV; Chinol M; Palestro CJ; Manzo C; Ferrone S
Int J Cancer; 1998 Nov; 78(4):486-90. PubMed ID: 9797138
[TBL] [Abstract][Full Text] [Related]
18. High affinity restricts the localization and tumor penetration of single-chain fv antibody molecules.
Adams GP; Schier R; McCall AM; Simmons HH; Horak EM; Alpaugh RK; Marks JD; Weiner LM
Cancer Res; 2001 Jun; 61(12):4750-5. PubMed ID: 11406547
[TBL] [Abstract][Full Text] [Related]
19. Antigen specificity and tumour targeting efficiency of a human carcinoembryonic antigen-specific scFv and affinity-matured derivatives.
Jackson H; Bacon L; Pedley RB; Derbyshire E; Field A; Osbourn J; Allen D
Br J Cancer; 1998 Jul; 78(2):181-8. PubMed ID: 9683291
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of melanoma growth by targeting of antigen to dendritic cells via an anti-DEC-205 single-chain fragment variable molecule.
Johnson TS; Mahnke K; Storn V; Schönfeld K; Ring S; Nettelbeck DM; Haisma HJ; Le Gall F; Kontermann RE; Enk AH
Clin Cancer Res; 2008 Dec; 14(24):8169-77. PubMed ID: 19088032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
